|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.3 HKD | +1.10% |
|
+15.56% | -13.75% |
| 04-26 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
RemeGen Co., Ltd. (SEHK:9995) said it aims to raise up to CNY 2.55 billion ($353.20 million) in A-share private placement to fund new drug development project.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.75% | 3.55B | |
| +2.97% | 108B | |
| +10.21% | 105B | |
| +1.57% | 23.46B | |
| -12.77% | 21.72B | |
| -7.05% | 18.64B | |
| -37.64% | 17.45B | |
| -6.50% | 17.19B | |
| +6.00% | 13.99B | |
| +37.20% | 12.53B |
REMEGEN CO., LTD. 